Brief: Acrux Announces Almirall LLC Patent Litigation Against Acrux
08/06/2021 24:36
June 8 (Reuters) - Acrux Ltd ACR.AX :
* ACRUX CONFIRMS PATENT CHALLENGE
* ANNOUNCED ALMIRALL LLC HAS INITIATED PATENT LITIGATION
AGAINST
ACRUX IN U.S. DISTRICT COURT FOR DISTRICT OF NEW JERSEY
* LITIGATION REGARDING CO'S PARAGRAPH IV ABBREVIATED NEW
DRUG
APPLICATION (ANDA) FOR DAPSONE GEL 7.5%
Source text for Eikon: ID:nASX2HFPMH
Further company coverage: ACR.AX
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share